HELPTAG:MemberID

Apr 8, 2020

MemberID or Email Address:
Latest in Home
Heart Pulmonary Trunk Social
AI-powered blood test supports risk stratification of heart disease patients
November 27, 2023
Stock Exchange Social
Nasdaq issues delisting notice to T2 Biosystems
November 27, 2023
Sepsis Bacteria Social
Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test
November 22, 2023
Colorectal Cancer Social
Universal DX partners with Quest Diagnostics, closes $70M series B financing round
November 21, 2023
Related Stories
2019 11 01 22 16 2253 Hahn Stephen 20191101221734
Home
Senate confirms Hahn as FDA commissioner
2019 11 01 22 16 2253 Hahn Stephen 20191101221734
Home
Hahn nominated to lead FDA as commissioner
2019 08 26 19 10 2762 Lab Blood Man 400
Home
Blood test detects concussions not visible on CT scans
2019 08 08 18 01 3923 Zabaleta Eugenio Aacc 2019 400
Home
Video from AACC 2019: How to get physicians to order the right lab test
More in Home
AI-powered blood test supports risk stratification of heart disease patients
A blood test powered by artificial intelligence (AI) has shown promise in the assessment of patients with total blockage of a heart artery.
November 27, 2023
Heart Pulmonary Trunk Social
Nasdaq issues delisting notice to T2 Biosystems
T2 Biosystems has received a delisting notice from Nasdaq after failing to satisfy the minimum $35 million market value of listed securities threshold required to remain listed.
November 27, 2023
Stock Exchange Social
Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test
Siemens Healthineers has secured a three-year, $5.5 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health, to develop a test to improve sepsis treatment.
November 22, 2023
Sepsis Bacteria Social
Universal DX partners with Quest Diagnostics, closes $70M series B financing round
Liquid biopsy firm Universal DX and Quest Diagnostics have formed a strategic collaboration under which Quest will exclusively offer services for Universal DX’s Signal-C colorectal cancer screening test in the U.S.
November 21, 2023
Colorectal Cancer Social
Bit.bio unveils cell therapy candidate for liver conditions
Synthetic biology company bit.bio has unveiled a lead cell therapy candidate as a treatment for life-threatening liver conditions, and it has set out its broader cell therapy pipeline.
November 22, 2023
Liver Anatomy Social
AMP, other stakeholders urge Congress to pause FDA LDT rule, update CLIA
The Association for Molecular Pathology (AMP) requested Congress to update the Clinical Laboratory Improvement Amendments (CLIA) as an alternative to the FDA’s proposed rule to increase agency oversight of laboratory-developed tests (LDTs).
November 22, 2023
Washington Dc Capitol Social
U.K. regulators approve "world-first" sickle-cell gene therapy
U.K. medical regulators have approved a “world-first” gene therapy that aims to cure two blood disorders: sickle cell disease and transfusion-dependent β-thalassemia. They are the first regulatory body to approve the treatment.
November 20, 2023
Sickle Cell Anemia2 Social
AI concurs with humans in heart failure test, suggesting scalable approach to clinical trials
Artificial intelligence (AI) may make clinical trials more efficient by accurately identifying events at scale, a retrospective analysis has found.
November 21, 2023
Computer Heart Social
Nanopore Technologies, Day Zero Diagnostics to collaborate on sepsis diagnostic solution
Oxford, U.K.-based Oxford Nanopore Technologies and Boston-based infectious disease diagnostics firm Day Zero Diagnostics have announced a partnership to develop an end-to-end solution for the diagnosis of bloodstream infections.
November 20, 2023
Bacteria Blood Sepsis Social
10x Genomics awarded $31M in patent infringement lawsuit against NanoString Technologies
10x Genomics has been awarded more than $31 million in damages by a jury in the U.S. District Court for the District of Delaware in its patent infringement lawsuit against NanoString Technologies.
November 20, 2023
Gavel Money Social
Exact Sciences files patent infringement lawsuit against Geneoscopy
Exact Sciences has filed a patent infringement lawsuit against Geneoscopy alleging that Geneoscopy’s recently launched colorectal screening test infringes on a patented method used in Exact Science’s Cologuard assay.
November 17, 2023
Lawsuit Social
Verici DX, Thermo Fisher Scientific sign licensing agreement on pre-transplant prognostic test
Transplant diagnostic firm Verici DX and Thermo Fisher Scientific have signed an exclusive global licensing and commercialization agreement to develop a pre-transplant prognostic test for early kidney rejection risk assessment.
November 17, 2023
Kidneys Closeup Social
Page 1 of 100
Next Page